Last updated: 2026-09-25 15:20:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Hims & Hers Health, Inc. (HIMS) operates in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE sector and is listed on NYSE. The stock is currently priced at $29.33, with a market capitalization of $6.62B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.74 to $65.30. This page covers its latest market performance, valuation, price trends and company information.
$6.62B | |
$29.48 | |
$72.98 | |
$2.72 | |
$29.28 | |
2.29M | |
13.04M | |
-- | |
$65.30 | |
$13.74 | |
-- | |
-- |
Hims & Hers Health, Inc. (HIMS) is currently trading at $29.33 as of 2026-09-25 15:04:57, up 0.17% ($0.05) from the previous close of $29.28
During today's regular trading session, HIMS has traded between $2.72 and $72.98, with a trading volume of 2.29M shares. The current price is near the middle of today's range.
Over the past seven days, Hims & Hers Health, Inc. (HIMS) moved from $28.00 to $29.33, representing a gain of 4.75% ($1.33).
The stock traded between $27.31 and $31.81 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 11.24 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 30.2%
HIMS is currently trading at $29.33, placing it 30.2% of the way from its 52-week low of $13.74 to its 52-week high of $65.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Employees | 2442 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Hims & Hers Health, Inc. (HIMS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.